This inventor holds 21 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Smithkline Beecham Corporation, Glaxosmithkline LLC, Other. Active years: 1997-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- US (1998)
- Doylestown, PA (US) (1997 - 2003)
- King of Prussia, PA (US) (2003 - 2005)
- Collegeville, PA (US) (2003 - 2010)
Company Filing History:
19 out of 2,198 
1 out of 358 
1 out of 834,601 Years Active: 1997-2010
Areas of Expertise:
Title: Innovations and Contributions of Jack Dale Leber
Introduction
Jack Dale Leber, based in Collegeville, PA, is an accomplished inventor with a remarkable portfolio, holding 21 patents to his name. His work primarily focuses on developing novel compounds with significant applications in the medical field. His inventions are paving the way for advancements in cancer treatment and other therapeutic areas.
Latest Patents
Among his latest achievements, Leber has developed peptide deformylase inhibitors, introducing innovative methods and compounds that could revolutionize existing protocols in drug development. Additionally, he has invented substituted imidazo[4,5-c]pyridine compounds that serve as Akt inhibitors. These novel 1H-imidazo[4,5-c]pyridin-2-yl compounds are particularly noteworthy for their potential efficacy in inhibiting protein kinase B activity, which plays a critical role in the treatment of cancer and arthritis.
Career Highlights
Throughout his career, Jack Dale Leber has been associated with significant organizations, including SmithKline Beecham Corporation. His contributions have enhanced the company's research capabilities, solidifying his impact in the pharmaceutical and biotechnology sectors.
Collaborations
Leber has collaborated with esteemed colleagues, such as John Duncan Elliott and Russell Donovan Cousins, further enriching his research endeavors. These partnerships have fostered a collaborative environment that has led to innovative solutions and transformative discoveries in the field of therapeutics.
Conclusion
Jack Dale Leber's innovations and diligent work in developing novel compounds are commendable. His extensive patent portfolio stands as a testament to his contribution to the field of medicine, particularly in cancer research and treatment. As he continues to pave the way for future advancements, his work inspires many in the ongoing quest for innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile